DataArt today announced its ongoing development work for Passlogix®, Inc., the global leader in password and access management solutions.
DataArt has provided a variety of technology services to Passlogix since 2006 to support continuing upgrades and enhancements to the company’s v-GO™ Access Accelerator Suite™, helping to speed time to market by providing third-party software engineering and validation services.
“Working with DataArt helps us ensure that we can deliver innovative new functionality as well as maintenance upgrades in a timely manner,” said Marc Manza, chief technology officer at Passlogix. “We use DataArt’s services to help our talented team of in-house software engineers, particularly when we need extra specialists to meet aggressive deadlines for new releases or additions to our v-GO suite.”
Passlogix’s v-GO Access Accelerator Suite is an integrated set of single sign-on, provisioning and authentication solutions designed to speed user access to applications throughout the extended enterprise. The suite components help organizations improve business productivity, strengthen enterprise security and regulatory compliance readiness, and streamline identity management deployments.
DataArt executive participated in "America's Most Beautiful Bike Ride" for the Leukemia and Lymphoma Society (LLS) on June 7, 2009 around Lake Tahoe.
Girish Nair, Senior Vice President of Business Development at DataArt, rode the 100 miles as a member of The Blackstone Group Team, which raised $200,000. Girish raised $4,600, with DataArt contributing half of the amount. Part of the Blackstone Team was iLevel Solutions, a new client for DataArt.
Over 3,500 people participated in the ride, with LLS TNT (Team in Training) raising more than $6.8M in the support of the fight against blood cancers. "The ride was a tremendously moving event and demonstrated what motivated people can do to help find a cure for blood cancer," said Nair.
The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. It has invested more than $600 million in research since 1949 - over $71 million in 2008 - specifically targeting leukemia, lymphoma and myeloma. Last year alone, LLS made 6.3 million contacts with patients, caregivers and healthcare professionals.
www.teamintraining.org
